Evidence map›Paper›PMID 42525124›Full record

ArticleEndocrine connections2026

11-deoxycortisol, other hormones and pituitary function characteristics in the diagnosis of adrenal insufficiency in the overnight oral metyrapone test.

Alexander Krawzow, Mirko Peitzsch, Manuela Bastian, Till Postrach, Lisa Johanna Harms, Elena Novikova, Graeme Eisenhofer, Holger S Willenberg

Abstract read
In one paragraph

Article in Endocrine connections, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Alexander KrawzowDivision of Endocrinology and Metabolism, Department of Medicine, Rostock University Medical Center , Rostock, Germany.
Mirko PeitzschInstitute of Clinical Chemistry and Laboratory Medicine, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden , Dresden, Germany.
Manuela BastianInstitute for Clinical Chemistry and Laboratory Medicine, Rostock University Medical Center , Rostock, Germany.
Till PostrachDivision of Endocrinology and Metabolism, Department of Medicine, Rostock University Medical Center , Rostock, Germany.
Lisa Johanna HarmsDivision of Endocrinology and Metabolism, Department of Medicine, Rostock University Medical Center , Rostock, Germany.
Elena NovikovaDivision of Endocrinology and Metabolism, Department of Medicine, Rostock University Medical Center , Rostock, Germany.
Graeme EisenhoferDepartment of Medicine III, University Hospital Carl Gustav Carus, Technische Universität Dresden , Dresden, Germany.
Holger S WillenbergDivision of Endocrinology and Metabolism, Department of Medicine, Rostock University Medical Center , Rostock, Germany.ORCID 0000-0001-5362-7075

Funding

FORUN program of the Rostock University Medical Center 889118
6 · The paper itself

Abstract

abstractThe oral metyrapone test is utilized to assess pituitary adrenal axis function. We asked whether 17-hydroxyprogesterone, androstenedione or corticotropin are similarly as useful as 11-deoxycortisol to detect adrenal insufficiency. Of the SHIP-PAGE study participants, 190 patients underwent an oral metyrapone test. The diagnosis of adrenal insufficiency included information from the clinical course, concentrations of adrenal steroids and ACTH before or after metyrapone as well as results of other pituitary function tests. Of the 190 patients, 67 had adrenal insufficiency and 123 had not. ROC analysis showed the highest sensitivity (83%), specificity (>90%) and area under the curve (0.9) for 11-deoxycortisol at a cutoff of 197 nmol/L. Surges in 11-deoxycortisol were related to those of 17-hydroxyprogesterone, androstenedione and corticotropin that displayed lower sensitivities, specificities and areas under the curve with cutoff values of 5.55 nmol/L, 8.11 nmol/L and 89.60 pg/mL, respectively. The presence of gonadal dysfunction had a high sensitivity of 61% and prolactin deficiency a high specificity (96%) for prediction of adrenal insufficiency as had a combined dysfunction of the gonadal, growth hormone and thyroid axes (97%). In conclusion, 11-deoxycortisol is an already established parameter with a good performance in the oral metyrapone test, which was not outperformed by 17-hydroxyprogesterone, androstenedione or corticotropin. However, there may be a substantial bias to this result. Therefore, determination of pituitary-end-organ axes functions is likewise helpful to provide probability information in the assessment of adrenal insufficiency, which remains a diagnosis based on clinical information and endocrine function tests. SIGNIFICANCE STATEMENT: The oral metyrapone test is very useful for the characterization of adrenal function. If available, analysis of 11-deoxycortisol is better than measurements of other adrenal steroid hormones or corticotropin. However, there may be a bias from previous studies on the metyrapone test. Therefore, analysis of corticotropin, androstenedione and 17-hydroxyprogesterone concentrations at baseline and the day after metyrapone administration is also very helpful for the evaluation of adrenal function when the results from other pituitary function tests are included in the diagnostic process.

Indexed as

adrenal insufficiencycortisolmetyraponepituitary tumorsteroid hormones

Identifiers

PMID42525124
PMCPMC13459089

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.